News

Proteins are the infinitely varied chemicals that make cells work, and science has a pretty good idea how they are made. But ...
Although Merkel cell carcinoma (MCC) is rare, it is highly malignant. Research into the etiologic basis of many other skin cancers has progressed significantly, but MCC causation remains obscure.
A research group has developed a technology for mass-producing uniform artificial cells (lipid bilayer vesicles) with artificial model nuclei using microfluidic devices with high reproducibility. They ...
Diagram of generic plant and animal cells, showing major organelles including nucleus, nucleolus, rough endoplasmic reticulum, smooth endoplasmic reticulum, cell membranes, golgi apparatus, ...
Incyte (Nasdaq:INCY) today announced that primary results from the Phase 3 POD1UM-303/InterAACT 2 trial of retifanlimab (Zynyz ® ), a humanized monoclonal antibody targeting programmed death ...
Basal cell carcinoma is the most common type of cancer. If you’ve been diagnosed with basal cell carcinoma (BCC), you have plenty of company. Basal cell carcinoma is the most common type of skin ...
Company anticipates initiating its Phase 3 accelerated approval trial of IFx-Hu2.0 as adjunctive therapy with Keytruda® (pembrolizumab) as first-line treatment for advanced and metastatic Merkel ...
TuHURA Biosciences advances its phase 3 trial of IFx-2.0 for Merkel cell carcinoma, aiming to enhance immune response alongside pembrolizumab. The FDA has lifted a partial clinical hold related to ...